20/20 HealthCare Partners Announces $12 Million Investment in Corindus.AUBURNDALE, Mass. -- 20/20 HealthCare Partners LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control is pleased to announce that its portfolio company, Corindus, Inc., closed a B Round investment taken solely by a New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of based hedge fund hedge fund, in finance, a highly speculative, largely unregulated investment device. Originating in the 1950s, the funds "hedge" by offsetting "short" positions (borrowing a security and then selling it at a higher price before repaying the lender) against "long" / private equity fund specializing in the healthcare industry. Corindus will use the financing to enhance its management structure, complete product development and obtain regulatory approvals in the US and Europe. The initial funding round led by 20/20 HealthCare Partners in September 2005 enabled Corindus to progress from an early stage company through development of a sophisticated, fully functional robotic catheterization catheterization Threading of a flexible tube (catheter) through a channel in the body to inject drugs or a contrast medium, measure and record flow and pressures, inspect structures, take samples, diagnose disorders, or clear blockages. system for the CathLab. 20/20 HCP HCP, n healthcare provider, a professional who specializes in treating and managing a person's general or specific health needs. Managing Partner, Hillel Bachrach says, "20/20 HCP had the early vision of the tremendous potential impact this technology would have on the delivery of consistent quality in the CathLab at an ever safer environment to the doctor and patient; realizing the potential led to 20/20 HCP funding the A round." About 20/20 HealthCare Partners LLC 20/20 HealthCare Partners LLC provides equity financing Equity Financing The act of raising money for company activities by selling common or preferred stock to individual or institutional investors. In return for the money paid, shareholders receive ownership interests in the corporation. for promising growth businesses as well as for buyouts or recapitalizations of established companies specializing in the Medical Technology industry. 20/20 HealthCare Partners works with management to streamline product development, regulatory approval and market penetration. Their group of industry experienced professionals is able to introduce portfolio companies to strategic partnerships. Their relationships help expedite the product development cycle and shorten the time to market - and increase company value. 20/20 HCP provides portfolio companies with tools such as active support in strategic vision, development of distribution channels, an impressive network of industry contacts, and years of industry expertise to achieve maximized growth and value leading to a potential realization. For more information, please visit www.2020hcp.com or call 617-244-9050. About Corindus Corindus designs and manufactures patented robotic systems developed to support the treatment of coronary artery and peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . The company's proprietary robotic technology, The CorPath[TM] robotic PCI (1) (Payment Card Industry) See PCI DSS. (2) (Peripheral Component Interconnect) The most widely used I/O bus (peripheral bus). system, enables physicians to position interventional devices and deliver balloon/stent catheters with precision from a remote location beyond the radiation zone. Corindus is committed to providing innovative robotic navigation technologies to the interventional cardiology and peripheral vascular fields. The CorPath[TM] System requires regulatory clearance and is currently used for investigational purposes only. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion